Dividend Aristocrats vs Dividend Kings: Which Belong in Your DRIP Portfolio?

Updated June 2025 · 10 min read · My DRIP Plan

The terms "Dividend Aristocrat" and "Dividend King" get thrown around interchangeably in investing discussions, but they mean very different things. Understanding the distinction — and more importantly, what it means for a dividend reinvestment strategy — helps you make better decisions about which individual stocks to hold and why.

The Definitions

A Dividend King is a higher bar than an Aristocrat — 50 consecutive years of increases vs 25. But here's what surprises most investors: not all Dividend Kings are Dividend Aristocrats. The Aristocrat designation requires S&P 500 membership; many Kings are smaller companies not included in that index.

And not all Aristocrats are Kings — many companies have maintained 25–49 consecutive years of increases but haven't yet crossed the 50-year threshold. They're Aristocrats in waiting.

What 25 or 50 Consecutive Years Actually Means

These streaks are more impressive than they sound. Consider what a company raising its dividend in 2025 for the 50th consecutive year had to survive:

• The 1973–74 oil crisis and stagflation
• The early 1980s recession (unemployment near 11%)
• The 1987 Black Monday crash (market down 22% in one day)
• The 1990–91 Gulf War recession
• The 2000–02 dot-com collapse
• The 2008–09 financial crisis (worst since the Great Depression)
• The 2020 COVID pandemic
• The 2022 rate hike cycle

Every single year, through every one of those events, these companies found a way to pay shareholders more than the prior year. That's not luck — it's the result of durable business models, conservative balance sheets, and management discipline that spans multiple generations of leadership.

Examples of Dividend Kings (50+ Years)

*3M cut its dividend in 2024 following the Solventum spinoff. The streak controversy highlights that spinoffs can disrupt these lists. Always verify current streak status. Yields approximate.

Examples of Dividend Aristocrats (25–49 Years)

*AbbVie's streak includes Abbott Laboratories pre-spinoff. Yields and streak counts approximate and change over time.

For DRIP: Does the Title Matter More Than the Fundamentals?

This is the key question. The Aristocrat and King designations are useful as initial filters, but they're backward-looking. What matters for DRIP is the dividend growth rate going forward — and that's driven by the company's current financial position, not how many years they've already raised.

A company with 60 consecutive dividend increases but a 90% payout ratio and declining earnings is more likely to cut than a company with 28 consecutive increases, a 45% payout ratio, and accelerating free cash flow. The streak tells you about the past. The balance sheet tells you about the future.

That said, the streak is not meaningless — it's evidence that management is deeply committed to protecting the dividend even through hard times. Companies don't accidentally raise their dividend for 50 years. It reflects a culture and a capital allocation priority that tends to persist.

Which Performs Better for DRIP?

Dividend Kings, as a group, have historically provided lower dividend growth rates than Aristocrats. This makes intuitive sense — companies that have been raising dividends for 50+ years tend to be mature, slow-growing businesses (consumer staples, industrial conglomerates). Their dividends are rock-solid but grow at 3–5%/year rather than 8–12%.

Aristocrats include more companies in their growth phase — businesses like McDonald's, AbbVie, and Home Depot that have established the streak but still have significant room to grow. These often deliver better dividend growth rates and total returns for DRIP investors with longer horizons.

How to Build a DRIP Portfolio Using Both

A sample framework for a dividend-focused DRIP portfolio using Aristocrats and Kings:

This isn't a prescription — it's a framework. The right mix depends on your timeline, income needs, and risk tolerance. The important thing is that both Aristocrats and Kings have a legitimate role in a serious DRIP portfolio; neither should be ignored in favor of the other.

A Note on ETFs That Track These Lists

You don't have to pick individual stocks to get exposure to Aristocrats or Kings. Several ETFs track these categories:

• NOBL (ProShares S&P 500 Dividend Aristocrats ETF) — equal-weighted exposure to all ~65 Aristocrats, 0.35% expense ratio
• SDOG (ALPS Sector Dividend Dogs ETF) — dividend-focused but different methodology
• No major ETF tracks exclusively Dividend Kings due to the small universe size

NOBL is a reasonable option for investors who want broad Aristocrat exposure without picking individual stocks. The equal-weight approach gives smaller Aristocrats more representation than they'd have in a market-cap weighted fund. Expense ratio (0.35%) is higher than SCHD (0.06%) but still modest.

Frequently Asked Questions

Is a Dividend King better than a Dividend Aristocrat?

Not necessarily. "Better" depends on your goals. Dividend Kings have longer track records of consecutive increases (50+ vs 25+), which signals exceptional commitment to the dividend. But Aristocrats often include companies with higher dividend growth rates and more total return potential. For DRIP investors, a mix of both usually outperforms either alone.

How many Dividend Kings are there?

There are approximately 50–55 Dividend Kings as of 2025, though the exact count shifts as companies join (by crossing 50 years) or leave (by cutting or freezing their dividend). The list changes slowly — it's difficult to earn and easy to lose.

What happens if a Dividend Aristocrat cuts its dividend?

It's immediately removed from the Aristocrat index and from ETFs like NOBL at the next rebalancing. This is rare but does happen. Companies that cut typically do so during severe financial distress, which is why the years-of-consecutive-increases criterion is such a useful initial screen for dividend safety.

Can I just buy SCHD instead of picking individual Aristocrats and Kings?

Yes — and for most investors, this is the better approach. SCHD's index requires 10 consecutive years of dividends plus quality screens (cash flow, ROE, yield, dividend growth rate). It captures most of the same companies at lower cost and with better diversification than manually building an Aristocrat portfolio.